losartan has been researched along with Embolism, Pulmonary in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "APE-induced pulmonary hypertension is aggravated by active pulmonary vasoconstriction." | 5.38 | Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes. ( Dias, CA; Montenegro, MF; Neto-Neves, EM; Tanus-Santos, JE, 2012) |
| "APE-induced pulmonary hypertension is aggravated by active pulmonary vasoconstriction." | 1.38 | Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes. ( Dias, CA; Montenegro, MF; Neto-Neves, EM; Tanus-Santos, JE, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, CA | 1 |
| Neto-Neves, EM | 1 |
| Montenegro, MF | 1 |
| Tanus-Santos, JE | 1 |
| Matys, T | 1 |
| Kucharewicz, I | 1 |
| Pawlak, R | 1 |
| Chabielska, E | 1 |
| Domaniewski, T | 1 |
| Buczko, W | 1 |
2 other studies available for losartan and Embolism, Pulmonary
| Article | Year |
|---|---|
Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Hypertens | 2012 |
Nitric oxide-dependent antiplatelet action of AT1-receptor antagonists in a pulmonary thromboembolism in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Imidazoles; Injections, I | 2003 |